You are here

  • Home
  • Archive
  • Volume 12, Issue 5
  • Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer

Article info

Article menu
Immunotherapy biomarkers
Original research
Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer

Authors

  • Zhen Han Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine,Southern Medical University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhicheng Zhang Department of Gastroenterology, The First Hospital of Jilin University, Changchun, Jilin, ChinaJancsiLab, JancsiTech, Hongkong, China PubMed articlesGoogle scholar articles
  • Xianqi Yang Department of Gastric Surgery, and State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhe Li School of Computer Science and Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Shengtian Sang Department of Radiology, Stanford University School of Medicine, Stanford, California, USA PubMed articlesGoogle scholar articles
  • Md Tauhidul Islam Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA PubMed articlesGoogle scholar articles
  • Alyssa A Guo Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA PubMed articlesGoogle scholar articles
  • Zihan Li Department of Bioengineering, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Xiaoyan Wang Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Jing Wang Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Taojun Zhang Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine,Southern Medical University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Zepang Sun Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine,Southern Medical University, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Lequan Yu Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, Hong Kong PubMed articlesGoogle scholar articles
  • Wei Wang Department of Gastric Surgery, and State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Wenjun Xiong Department of Gastrointestinal Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Guoxin Li Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine,Southern Medical University, Guangzhou, Guangdong, ChinaSchool of Clinical Medicine, Tsinghua University, Beijing Tsinghua Changgung Hospital, Beijing, China PubMed articlesGoogle scholar articles
  • Yuming Jiang Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA PubMed articlesGoogle scholar articles

Citation

Han Z, Zhang Z, Yang X, et al
Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer
Journal for ImmunoTherapy of Cancer 2024;12:e008927. doi: 10.1136/jitc-2024-008927
Online issue publication 
May 15, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.